• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDC37L1通过下调CDK6发挥胃癌迁移和增殖抑制因子的作用。

CDC37L1 acts as a suppressor of migration and proliferation in gastric cancer by down-regulating CDK6.

作者信息

Li Li, Tao Xinyi, Li Yandong, Gao Yong, Li Qinchuan

机构信息

Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.

Department of Medical Experimental Techniques, Jinzhou Medical University, Jinzhou 121001, China.

出版信息

J Cancer. 2021 Mar 31;12(11):3145-3153. doi: 10.7150/jca.56097. eCollection 2021.

DOI:10.7150/jca.56097
PMID:33976724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100790/
Abstract

The co-chaperone protein CDC37 (Cell division cycle 37) is well known to regulate multiple protein kinases and involved in tumor progression. However to date, little is known about its analogue CDC37L1 (Cell division cycle 37 like 1) in tumorigenesis. This study aimed to explore the expression and function of CDC37L1 in gastric cancer (GC). The immunohistochemical staining in a tissue microarray showed a weak expression of CDC37L1 in high grade GC tissues compared with low grade tissues. Consistently, data from online database analysis demonstrated that CDC37L1 level was decreased in stage 4 patients and low expression of CDC37L1 indicated a poor prognosis. Functional studies revealed that CDC37L1 could inhibit GC cell proliferation and migration in CCK8, EdU incorporation, colony formation and transwell assays. In the meantime, CDC37L1 also inhibited the tumorigenicity of GC cells in nude mice. Mechanistically, we found that CDC37L1 had an impact on CDK6 protein expression by western blotting. Palbociclib, a specific CDK4/6 inhibitor, was discovered to block the rapid growth phenotype of GC cells induced by CDC37L1 silencing. Taken together, these findings unveiled a tumor-suppressive role of CDC37L1 in GC, and CDK6 may act as a downstream effector in this process.

摘要

共伴侣蛋白CDC37(细胞分裂周期37)在调节多种蛋白激酶及参与肿瘤进展方面广为人知。然而,迄今为止,关于其类似物CDC37L1(类细胞分裂周期37 1)在肿瘤发生中的作用却知之甚少。本研究旨在探讨CDC37L1在胃癌(GC)中的表达及功能。组织芯片的免疫组化染色显示,与低级别GC组织相比,高级别GC组织中CDC37L1表达较弱。同样,在线数据库分析数据表明,IV期患者中CDC37L1水平降低,且CDC37L1低表达提示预后不良。功能研究显示,在CCK8、EdU掺入、集落形成和Transwell实验中,CDC37L1可抑制GC细胞增殖和迁移。同时,CDC37L1还可抑制GC细胞在裸鼠中的致瘤性。机制上,我们通过蛋白质印迹法发现CDC37L1对CDK6蛋白表达有影响。发现特异性CDK4/6抑制剂帕博西尼可阻断由CDC37L1沉默诱导的GC细胞快速生长表型。综上所述,这些发现揭示了CDC37L1在GC中的肿瘤抑制作用,且CDK6可能在此过程中作为下游效应分子发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/13f896ff88a8/jcav12p3145g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/9a04d95b6ae9/jcav12p3145g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/bd89477b6ed4/jcav12p3145g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/78353d508cb9/jcav12p3145g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/a87c68af8173/jcav12p3145g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/22c8bc4cb761/jcav12p3145g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/13f896ff88a8/jcav12p3145g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/9a04d95b6ae9/jcav12p3145g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/bd89477b6ed4/jcav12p3145g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/78353d508cb9/jcav12p3145g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/a87c68af8173/jcav12p3145g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/22c8bc4cb761/jcav12p3145g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea58/8100790/13f896ff88a8/jcav12p3145g006.jpg

相似文献

1
CDC37L1 acts as a suppressor of migration and proliferation in gastric cancer by down-regulating CDK6.CDC37L1通过下调CDK6发挥胃癌迁移和增殖抑制因子的作用。
J Cancer. 2021 Mar 31;12(11):3145-3153. doi: 10.7150/jca.56097. eCollection 2021.
2
facilitates the growth and development of gastric cancer by activating .通过激活促进胃癌的生长和发展。
Ann Transl Med. 2023 Jan 31;11(2):97. doi: 10.21037/atm-22-5933.
3
miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation.miR-15a和miR-20b通过抑制CDC37L1以及随后的PPIA下调,使肝癌细胞对索拉非尼敏感。
Cell Death Discov. 2022 Jun 27;8(1):297. doi: 10.1038/s41420-022-01094-2.
4
circZNF609 promotes the proliferation and migration of gastric cancer by sponging miR-483-3p and regulating CDK6.环状锌指蛋白609通过吸附微小RNA-483-3p并调控细胞周期蛋白依赖性激酶6来促进胃癌的增殖和迁移。
Onco Targets Ther. 2019 Oct 4;12:8197-8205. doi: 10.2147/OTT.S193031. eCollection 2019.
5
MiR-29c suppresses cell invasion and migration by directly targeting CDK6 in gastric carcinoma.miR-29c 通过直接靶向 CDK6 抑制胃癌中的细胞侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7920-7928. doi: 10.26355/eurrev_201909_19006.
6
The role of TRPV1 ion channels in the suppression of gastric cancer development.瞬时受体电位香草酸亚型1离子通道在抑制胃癌发生中的作用。
J Exp Clin Cancer Res. 2020 Oct 2;39(1):206. doi: 10.1186/s13046-020-01707-7.
7
Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.环状 RNA circ-DONSON 通过依赖 NURF 复合物的转录因子 SOX4 激活促进胃癌生长和侵袭。
Mol Cancer. 2019 Mar 28;18(1):45. doi: 10.1186/s12943-019-1006-2.
8
MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A.微小RNA-4316通过直接靶向血管内皮生长因子A抑制胃癌的增殖和迁移。
Cancer Cell Int. 2020 Feb 22;20:62. doi: 10.1186/s12935-020-1132-3. eCollection 2020.
9
Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins.MRPL35的缺失通过调节下游信号蛋白抑制胃癌细胞增殖。
World J Gastroenterol. 2021 Apr 28;27(16):1785-1804. doi: 10.3748/wjg.v27.i16.1785.
10
[miRNA-191-5p represses cell growth by targeting CDK6 in gastric cancer].[微小RNA-191-5p通过靶向细胞周期蛋白依赖性激酶6抑制胃癌细胞生长]
Zhonghua Yi Xue Za Zhi. 2020 Dec 15;100(46):3689-3693. doi: 10.3760/cma.j.cn112137-20200407-01111.

引用本文的文献

1
Whole-Genome Sequencing Reveals Individual and Cohort Level Insights into Chromosome 9p Syndromes.全基因组测序揭示了对9号染色体短臂综合征的个体和队列水平见解。
medRxiv. 2025 Mar 30:2025.03.28.25324850. doi: 10.1101/2025.03.28.25324850.
2
Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy.针对脊髓性肌萎缩症的 SMN2 靶向剪接调节小分子治疗的多样化靶点。
Nucleic Acids Res. 2023 Jul 7;51(12):5948-5980. doi: 10.1093/nar/gkad259.
3
The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer.

本文引用的文献

1
The role of CDK6 in cancer.CDK6 在癌症中的作用。
Int J Cancer. 2020 Dec 1;147(11):2988-2995. doi: 10.1002/ijc.33054. Epub 2020 May 30.
2
A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation.长非编码 RNA Lnc712 调控乳腺癌细胞增殖。
Int J Biol Sci. 2020 Jan 1;16(1):162-171. doi: 10.7150/ijbs.36429. eCollection 2020.
3
MZF1 and SCAND1 Reciprocally Regulate Gene Expression in Prostate Cancer.MZF1和SCAND1相互调节前列腺癌中的基因表达。
细胞周期蛋白和细胞周期蛋白依赖性激酶在胃癌发生发展中的调控。
Int J Mol Sci. 2023 Feb 2;24(3):2848. doi: 10.3390/ijms24032848.
4
The dual role of microRNA (miR)-20b in cancers: Friend or foe?微小 RNA(miR)-20b 在癌症中的双重作用:是敌是友?
Cell Commun Signal. 2023 Jan 30;21(1):26. doi: 10.1186/s12964-022-01019-7.
Cancers (Basel). 2019 Jun 8;11(6):792. doi: 10.3390/cancers11060792.
4
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.CDK4/6 抑制剂在乳腺癌中的应用:当前的争议与未来方向。
Curr Oncol Rep. 2019 Feb 26;21(3):25. doi: 10.1007/s11912-019-0769-3.
5
Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis.基于基因共表达网络分析的肝细胞癌预后基因
J Cell Biochem. 2019 Jul;120(7):11616-11623. doi: 10.1002/jcb.28441. Epub 2019 Feb 18.
6
Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma.肝细胞癌中用于构建竞争性内源性RNA调控网络的潜在预后基因的综合分析
Onco Targets Ther. 2019 Jan 14;12:561-576. doi: 10.2147/OTT.S188913. eCollection 2019.
7
Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures.CDK 抑制剂的最新研究进展:CDK/抑制剂共晶结构概述。
Eur J Med Chem. 2019 Feb 15;164:615-639. doi: 10.1016/j.ejmech.2019.01.003. Epub 2019 Jan 3.
8
Molecular Features Distinguish Gastric Cancer Subtypes.分子特征可区分胃癌亚型。
Int J Mol Sci. 2018 Oct 11;19(10):3121. doi: 10.3390/ijms19103121.
9
Structural insights into the functional diversity of the CDK-cyclin family.结构洞察细胞周期蛋白依赖性激酶-细胞周期蛋白家族的功能多样性。
Open Biol. 2018 Sep;8(9). doi: 10.1098/rsob.180112.
10
Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer.辛伐他汀通过抑制热休克蛋白 90 发挥作用,治疗三阴性乳腺癌。
Cancer Sci. 2018 Oct;109(10):3272-3284. doi: 10.1111/cas.13748. Epub 2018 Aug 26.